Cargando…

Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw

PURPOSE: Bisphosphonate - related osteonecrosis of the JAW (BRONJ) is a well known side effect of bisphosphonate therapies in oncologic and non oncologic patients. Since to date no definitive consensus has been reached on the treatment of BRONJ, novel strategies for the prevention, risk reduction an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cella, Luigi, Oppici, Aldo, Arbasi, Mariacristina, Moretto, Mauro, Piepoli, Massimo, Vallisa, Daniele, Zangrandi, Adriano, Di Nunzio, Camilla, Cavanna, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175443/
https://www.ncbi.nlm.nih.gov/pubmed/21849044
http://dx.doi.org/10.1186/1746-160X-7-16
_version_ 1782212152822595584
author Cella, Luigi
Oppici, Aldo
Arbasi, Mariacristina
Moretto, Mauro
Piepoli, Massimo
Vallisa, Daniele
Zangrandi, Adriano
Di Nunzio, Camilla
Cavanna, Luigi
author_facet Cella, Luigi
Oppici, Aldo
Arbasi, Mariacristina
Moretto, Mauro
Piepoli, Massimo
Vallisa, Daniele
Zangrandi, Adriano
Di Nunzio, Camilla
Cavanna, Luigi
author_sort Cella, Luigi
collection PubMed
description PURPOSE: Bisphosphonate - related osteonecrosis of the JAW (BRONJ) is a well known side effect of bisphosphonate therapies in oncologic and non oncologic patients. Since to date no definitive consensus has been reached on the treatment of BRONJ, novel strategies for the prevention, risk reduction and treatment need to be developed. We report a 75 year old woman with stage 3 BRONJ secondary to alendronate and pamidronate treatment of osteoporosis. The patient was unresponsive to recommended treatment of the disease, and her BRONJ was worsening. Since bone marrow stem cells are know as being multipotent and exhibit the potential for differentiation into different cells/tissue lineages, including cartilage, bone and other tissue, we performed autologous bone marrow stem cell transplantation into the BRONJ lesion of the patient. METHODS: Under local anesthesia a volume of 75 ml of bone marrow were harvested from the posterior superior iliac crest by aspiration into heparinized siringes. The cell suspension was concentrated, using Ficoll - Hypaque(® )centrifugation procedures, in a final volume of 6 ml. Before the injection of stem cells into the osteonecrosis, the patient underwent surgical toilet, local anesthesia was done and spongostan was applied as a carrier of stem cells suspension in the bone cavity, then 4 ml of stem cells suspension and 1 ml of patient's activated platelet-rich plasma were injected in the lesion of BRONJ. RESULTS: A week later the residual spongostan was removed and two weeks later resolution of symptoms was obtained. Then the lesion improved with progressive superficialization of the mucosal layer and CT scan, performed 15 months later, shows improvement also of bone via concentric ossification: so complete healing of BRONJ (stage 0) was obtained in our patient, and 30 months later the patient is well and without signs of BRONJ. CONCLUSION: To our knowledge this is the first case of BRONJ successfully treated with autologous stem cells transplantation with a complete response.
format Online
Article
Text
id pubmed-3175443
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31754432011-09-19 Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw Cella, Luigi Oppici, Aldo Arbasi, Mariacristina Moretto, Mauro Piepoli, Massimo Vallisa, Daniele Zangrandi, Adriano Di Nunzio, Camilla Cavanna, Luigi Head Face Med Case Report PURPOSE: Bisphosphonate - related osteonecrosis of the JAW (BRONJ) is a well known side effect of bisphosphonate therapies in oncologic and non oncologic patients. Since to date no definitive consensus has been reached on the treatment of BRONJ, novel strategies for the prevention, risk reduction and treatment need to be developed. We report a 75 year old woman with stage 3 BRONJ secondary to alendronate and pamidronate treatment of osteoporosis. The patient was unresponsive to recommended treatment of the disease, and her BRONJ was worsening. Since bone marrow stem cells are know as being multipotent and exhibit the potential for differentiation into different cells/tissue lineages, including cartilage, bone and other tissue, we performed autologous bone marrow stem cell transplantation into the BRONJ lesion of the patient. METHODS: Under local anesthesia a volume of 75 ml of bone marrow were harvested from the posterior superior iliac crest by aspiration into heparinized siringes. The cell suspension was concentrated, using Ficoll - Hypaque(® )centrifugation procedures, in a final volume of 6 ml. Before the injection of stem cells into the osteonecrosis, the patient underwent surgical toilet, local anesthesia was done and spongostan was applied as a carrier of stem cells suspension in the bone cavity, then 4 ml of stem cells suspension and 1 ml of patient's activated platelet-rich plasma were injected in the lesion of BRONJ. RESULTS: A week later the residual spongostan was removed and two weeks later resolution of symptoms was obtained. Then the lesion improved with progressive superficialization of the mucosal layer and CT scan, performed 15 months later, shows improvement also of bone via concentric ossification: so complete healing of BRONJ (stage 0) was obtained in our patient, and 30 months later the patient is well and without signs of BRONJ. CONCLUSION: To our knowledge this is the first case of BRONJ successfully treated with autologous stem cells transplantation with a complete response. BioMed Central 2011-08-17 /pmc/articles/PMC3175443/ /pubmed/21849044 http://dx.doi.org/10.1186/1746-160X-7-16 Text en Copyright ©2011 Cella et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Cella, Luigi
Oppici, Aldo
Arbasi, Mariacristina
Moretto, Mauro
Piepoli, Massimo
Vallisa, Daniele
Zangrandi, Adriano
Di Nunzio, Camilla
Cavanna, Luigi
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
title Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
title_full Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
title_fullStr Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
title_full_unstemmed Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
title_short Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
title_sort autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175443/
https://www.ncbi.nlm.nih.gov/pubmed/21849044
http://dx.doi.org/10.1186/1746-160X-7-16
work_keys_str_mv AT cellaluigi autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT oppicialdo autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT arbasimariacristina autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT morettomauro autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT piepolimassimo autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT vallisadaniele autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT zangrandiadriano autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT dinunziocamilla autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw
AT cavannaluigi autologousbonemarrowstemcellintralesionaltransplantationrepairingbisphosphonaterelatedosteonecrosisofthejaw